FDA and SAEC Link Gene Mutations to Liver Injury Associated with Antibiotic

Some people who receive flucloxacillin — a drug widely used in Europe and Australia, but not approved in the US — have variations in the HLA-B and HCP-5 genes, placing them at greater risk for drug-induced liver injury.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.